abbott see strength growth driver
rais fve
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jul
estim jul
price data jul
rate updat jul
currenc amount express
methodolog valu compani
abbott lab post stronger expect second-quart
perform weve moder rais fair valu
per share adjust project key
growth driver upward befit size
breadth abbott benefit wax new product
cycl off-set wane product cycl
robust growth fuel innov structur heart
diabet electrophysiolog heart failur outpac
establish pharmaceut nutrit
vascular cardiac rhythm manag product line
pleas see steadi stream new product
indic revenue growth medic devic segment
expect continu midterm especi
product begin tackl adopt
curv particular mitraclip indic expans
function mitral regurgit led stronger uptak
quarter wed anticip weve long thought
penetr fmr market signific opportun
transcathet mitral valv repair replac
technolog weve also held temper view adopt
cardiologist time-frame surgic intervent
valuabl unpredict patient patient
surg mitraclip growth suggest us
signific underli demand therapi
suspect intervent cardiologist also favor
technolog especi procedur
angioplasti grow slowli next-
gen mitraclip recent approv food drug
administr fda support strong
adopt version address
shortcom earlier version
navig size deploy
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
analyst note ep calcul divid net incom averag number common
abbott manufactur market medic devic blood glucos
monitor kit nutrit healthcar product diagnost product
equip brand gener drug product includ pacemak
stent cathet infant formula nutrit liquid adult molecular
point-of-car diagnost equip abbott deriv approxim
sale outsid unit state
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
note posit surround mitraclip
perform also bode well edward lifesci
pascal devic launch europ year
nonetheless abbott still enjoy enviabl headstart
 edward like receiv regulatori
approv
separ also impress strength flash
glucos monitor libr saw growth year
year libr offer larg type diabet popul real
improv tradit glucos meter requir
multipl fingerstick day manag indic
abbott plan roll expand capac year
anticip libr current review fda
offer featuresreal-tim alert glucos read
rang via bluetooth alarm indic loss connect
sensorthat make experi
similar continu glucos monitor dexcom
final recent clinic data libr demonstr type
patient use devic multipl daili insulin
inject abl significantli lower blood
glucos level outcom data along
competit price support on-go penetr
type market
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
